THUY-VY NGUYEN: Open Payments
NPI 1205490521 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,973 in 187 payments from 20 companies in 2025. Trend: 2023 $2,747 · 2024 $3,880 · 2025 $7,973
Food & beverage: $3,923Speaker / faculty: $3,150Consulting: $900
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $3,690 |
| Arcutis Biotherapeutics, Inc. | 15 | $1,083 |
| UCB, Inc. | 17 | $749 |
| Incyte Corporation | 14 | $393 |
| PFIZER INC. | 23 | $340 |
| Novartis Pharmaceuticals Corporation | 15 | $256 |
| GENZYME CORPORATION | 9 | $237 |
| E.R. Squibb & Sons, L.L.C. | 10 | $229 |
| Janssen Biotech, Inc. | 10 | $228 |
| LEO Pharma Inc. | 10 | $205 |
Products named: RINVOQ, Zoryve, Bimzelx, OPZELURA, DUPIXENT, CIBINQO, Sotyktu, TREMFYA.
Industry payments across CA — which companies pay providers there.
